Presentation of Celiac Disease in Finnish Children Is No Longer Changing: A 50-Year Perspective Laura Kivelä, BM, Katri Kaukinen, MD, PhD, Marja-Leena Lähdeaho, MD, PhD, Heini Huhtala, MSc, Merja Ashorn, MD, PhD, Tarja Ruuska, MD, PhD, Pauliina Hiltunen, MD, PhD, Jarmo Visakorpi, MD, PhD, Markku Mäki, MD, PhD, Kalle Kurppa, MD, PhD The Journal of Pediatrics Volume 167, Issue 5, Pages 1109-1115.e1 (November 2015) DOI: 10.1016/j.jpeds.2015.07.057 Copyright © 2015 Elsevier Inc. Terms and Conditions
Figure 1 A, Age, B, clinical presentation, C, severity of clinical presentation, and D, degree of small-bowel mucosal villous atrophy at diagnosis in 596 children with celiac disease divided into different time periods. The Journal of Pediatrics 2015 167, 1109-1115.e1DOI: (10.1016/j.jpeds.2015.07.057) Copyright © 2015 Elsevier Inc. Terms and Conditions
Figure 2 Annual incidence of children with positive tissue transglutaminase or EmAs admitted to Tampere University Hospital during 2001-2013 because of celiac disease suspicion. The Journal of Pediatrics 2015 167, 1109-1115.e1DOI: (10.1016/j.jpeds.2015.07.057) Copyright © 2015 Elsevier Inc. Terms and Conditions